Sun Pharma
Latest news, explainers and analysis on Sun Pharma. Tracking 9 stories on Arth Vani.
Connected in the graph
Latest on Sun Pharma
Sun Pharma to Cut US Drug Prices Amid Affordability Drive; Analysts See Limited Impact
Sun Pharmaceutical Industries has agreed to lower its drug prices in the United States, aligning them with other developed nations as part of an initiative to enhance healthcare affordability for low-income Americans. Despite the company's substantial US revenue, financial analysts believe this move will have only a minimal impact on Sun Pharma's overall financial performance.
BreakingSun Pharma Initiates Recall of Multiple Eye Drop Brands Across India Over Contamination
Sun Pharmaceutical Industries Ltd. has commenced a product withdrawal for several of its eye drop brands in India, citing contamination concerns. This recall affects a range of commonly used ophthalmic solutions, including Depopred, Brinolar, Brinzotim, Lotepred, Nepalact, and Toba-F products.
Tata Steel Net Profit Jumps 15%; Sun Pharma, Bajaj Finserv Q1 Results Expected Today
Indian stock markets concluded marginally higher today, with Tata Steel reporting a strong fifteen percent increase in its net profit for the June quarter. Investors are now keenly awaiting the first-quarter results from Sun Pharma and Bajaj Finserv, expected later today, for further market direction.
Sun Pharma Shares Register Weekly Growth, Signalling Positive Investor Mood
Sun Pharmaceutical Industries Ltd. shares have shown positive movement over the past week, indicating a favourable sentiment among investors. This weekly growth is a key point of interest for those tracking the pharmaceutical sector and Sun Pharma's market performance. It suggests increased buying interest for the company's stock.
Sun Pharma Leads 5 Nifty Stocks Showing Fresh Momentum: A Guide for Retail Traders
Five major Nifty 50 stocks, including Sun Pharmaceutical, are showing signs of price strength as a key momentum indicator moves into bullish territory. This shift suggests a positive change in investor sentiment and potential short-term opportunities for these blue-chip companies.
Sun Pharma Shares Slip Below Key Technical Support; Analysts Monitor Short-Term Weakness
India's largest pharmaceutical company, Sun Pharma, has witnessed a technical breakdown as its share price dropped below a critical support level. This movement suggests a potential period of volatility and short-term pressure for retail investors holding the stock.
Sun Pharma Stock Dips: Is This a Buying Opportunity or Sector Warning?
India's largest pharmaceutical company, Sun Pharma, has witnessed a notable decline in its share price over the past month. Investors are now weighing whether this dip represents a value-buying chance or signals a broader slowdown in the pharma sector.
Sun Pharma Shares See Short-Term Dip: What Retail Investors Need to Know
India's pharmaceutical giant, Sun Pharmaceutical Industries, has experienced a performance cooling over the last month. This dip is significant for retail investors as it directly impacts the valuation of major blue-chip portfolios and sectoral mutual funds.
Sun Pharma Stock Moves: Assessing India’s Largest Drugmaker Amid Market Fluctuations
Sun Pharmaceutical Industries is seeing active trading as a key Nifty 50 constituent. As India's top drugmaker, its performance remains a crucial indicator for retail investors and those holding pharma-sector mutual funds.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.